Effect of perioperative terlipressin infusion on systemic, hepatic, and renal hemodynamics during living donor liver transplantation

Journal of Critical Care

Volumn 28, Issue 5, 2013, Pages 775-782

  Fayed, N ^a   Refaat, E K ^a   Yassein, T E ^a   Alwaraqy, M ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Hemodynamics; Liver transplantation; Terlipressin

Indexed keywords

LACTIC ACID; TERLIPRESSIN; VASOACTIVE AGENT; VASOCONSTRICTOR AGENT;

ADULT; ARTERY RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MECHANISM; FEMALE; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HEPATIC HEMODYNAMICS; HUMAN; INFUSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION TEST; LACTATE BLOOD LEVEL; LIVER FUNCTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PERIOPERATIVE PERIOD; PORTAL VEIN BLOOD FLOW; REPERFUSION; RESISTIVE INDEX; SYSTEMIC HEMODYNAMICS; SYSTEMIC VASCULAR RESISTANCE; TREATMENT RESPONSE;

HEMODYNAMICS; LIVER TRANSPLANTATION; TERLIPRESSIN;

FEMALE; HEMODYNAMICS; HUMANS; LIVER CIRCULATION; LIVER TRANSPLANTATION; LIVING DONORS; LYPRESSIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL CIRCULATION; VASOCONSTRICTOR AGENTS;

EID: 84883555055     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.02.016     Document Type: Article

References (44)

1. Møller S. Systemic haemodynamics in cirrhosis and portal hypertension with focus on vasoactive substances and prognosis. Dan Med Bull 1998, 45:1-14.
2. Moreau R., Lebrec D. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond. Hepatology 2006, 43:385-394.
3. Salerno F., Gerbes A., Gines P., Wong F., Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007, 56:1310-1318.
4. Ouattara A., Landi M., Le M.Y., Lecomte P., Leguen M., Boccara G., et al. Comparative cardiac effects of terlipressin, vasopressin, and norepinephrine on an isolated perfused rabbit heart. Anesthesiology 2005, 102:85-92.
5. Augustin S., González A., Genescà J. Acute esophageal variceal bleeding: current strategies and new perspectives. World J Hepatol 2010, 2(7):261-274.
6. Mukhtar A., Salah M., Aboulfetouh F., et al. The use of terlipressin during living donor liver transplantation: effects on systemic and splanchnic hemodynamics and renal function. Crit Care Med 2011, 39(6):1329-1334.
7. Solanki P., Chawla A., Garg R., Gupta R., Jain M., Sarin S.K. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol 2003, 18:152-156.
8. Boucaud C., Bouffard Y., Dumortier J., Gaillac N., Sagnard P., Graber M.C., et al. Transesophageal echo-Doppler vs. thermodilution cardiac output measurement during hepatic vascular exclusion in liver transplantation. Eur J Anaesthesiol 2008, 25:485-489.
9. Dark P.M., Singer M. The validity of transesophaeal Doppler ultrasonography as a measure of cardiac output in critically ill adult. Intensive Care Med 2004, 30:2060-2066.
10. Colli A., Cocciolo M., Mumoli N., Cattalini N., Fraquelli M., Conte D. Hepatic artery resistance in alcoholic liver disease. Hepatology 1998, 28:1182-1186.
11. Halpern E.J., merton D.A., Forsberg F. Effect of distal resistance on Doppler ultrasound flow pattern. Radiology 1998, 206:761-766.
12. Lafortune M., Patriquin H. The hepatic artery: studies using Doppler sonography. Ultrasound Q 1999, 15:9-26.
13. Iwao T., Toyonaga A., Shigemori H., et al. Hepatic artery hemodynamic responsiveness to altered portal blood flow in normal and cirrhotic livers. Radiology 1996, 200:793.
14. García-Criado A., Gilabert R., Salmerón J.M., et al. Significance of and contributing factors for a high resistive index of Doppler sonography of the hepatic artery immediately after surgery: prognostic implications for liver transplant recipients. AJR 2003, 181:831-838.
15. Kastelan S., Ljubicic N., Kastelan Z., Ostojic R., Uravic M. The role of duplex-Doppler ultrasonography in the diagnosis of renal dysfunction and hepatorenal syndrome in patients with liver cirrhosis. Hepatogastroenterology 2004, 51(59):1408-1412.
16. Sacerdoti D., Bolognesi M., Merkel C., Angeli P., Gatta A. Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography. Hepatology 1993, 17:219-224.
17. Tote S.P., Grounds R.M. Performing perioperative optimization of the high risk patient. Br J Anaesth 2006, 97:4-11.
18. Kam P.C., Williams S., Yoong F.F. Vasopressin and terlipressin: pharmacology and its clinical relevance. Anaesthesia 2004, 59:993-1001.
19. Nilsson G., Lindblom P., Ohlin M., Berling R., Vernersson E. Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. Drugs Exp Clin Res 1990, 16:307-314.
20. Morelli A., Ertmer C., Lange M., et al. Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better?. Intensive Care Med 2007, 33:1669-1670.
21. Umgelter A., Reindl W., Schmid R.M., et al. Continuous terlipressin infusion in patients with persistent septic shock and cirrhosis of the liver. Intensive Care Med 2008, 34:390-391.
22. Møller S., Hansen E.F., Becker U., Brinch K., Henriksen J.H., Bendtsen F. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver 2000, 20:51-59.
23. Piscaglia F., Zironi G., Gaiani S., Mazziotti A., Cavallari A., Gramantieri L., et al. Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study. Hepatology 1999, 30:58-64.
24. Mandell M.S., Katz J.J., Wachs M., et al. Circulatory pathophysiology and options in hemodynamic management during adult liver transplantation. Liver Transpl Surg 1997, 3:379-387.
25. Kiszka-Kanowitz M., Henriksen J.H., Møller S., Bendtsen F. Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique. J Hepatol 2001, 35:605-612.
26. Henriksen J.H., Bendtsen F., Sørensen T.I.A., Stadeager C., Ring-Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology 1989, 97:1506-1513.
27. Hirasawa A., Shibata K., Kotosai K., Tsujimoto G. Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor. Biochem Biophys Res Commun 1994, 203:72-79.
28. Skagen C.L., Said A. Vasoconstrictor use in liver transplantation: is there evidence for rational use?. Minerva Gastroenterol Dietol 2010, 56:279-296.
29. Garutti Martinez I., Olmedella L., Perez-pena J.M., et al. Response to clamping of the inferior vena cava as a factor for predicting postreperfusion syndrome during liver transplantation. Anesth Analg 1997, 84:254-259.
30. Zahang L.P., Li N., Yang L. Effect of different vasopressors on hemodynamics in patients undergoing orthotopic liver transplantation. Chin Med J (Engl) 2005, 118:1952-1958.
31. Lenz K., Hörtnagl H., Druml W., et al. Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Gastroenterology 1991, 101:1060-1067.
32. Gadano A., Moreau R., Vachiery F., et al. Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites. J Hepatol 1997, 26:1229-1234.
33. Sagi S.V., Mittal S., Kasturi K.S., et al. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a metaanalysis of randomized controlled trials. J Gastroenterol Hepatol 2010, 25:880-885.
34. Hadengue A., Gadano A., Moreau R., et al. Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol 1998, 29:565-570.
35. Ku Y., Fukumoto T., Nishida T., Tominaga M., Maeda I., Kitagawa T., et al. Evidence that portal vein decompression improves survival of canine quarter orthotopic liver transplantation. Transplantation 1995, 59:1388-1392.
36. Man K., Lo C.M., Ng I.O., Wong Y.C., Qin L.F., Fan S.T., et al. Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg 2001, 136:280-285.
37. Sacerdoti D., Merkel C., Bolognesi M., Amodio P., Angeli P., Gatta A. Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: relationships with portal hemodynamics. Gastroenterology 1995, 108:1152-1158.
38. Bolognesi M., Sacerdoti D., Bombonato G., et al. Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size. Hepatology 2002, 35(3):601-608.
39. Narahara Y., Kanazawah H., Taki Y., et al. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis. J Gastroenterol Hepatol 2009, 24:1791-1797.
40. Wagener G., Gubitosa G., Renz J., et al. Vasopressin decrease portal vein pressure and flow in the native liver during liver transplantation. Liver Transpl 2008, 14:1664-1670.
41. Richter S., Mücke I., Menger M.D., Vollmar B. Impact of intrinsic blood flow regulation in cirrhosis: maintenance of hepatic arterial buffer response. Am J Physiol Gastrointest Liver Physiol 2000, 279:G454-G462.
42. Gülberg V., Haag K., Rössle M., Gerbes A.L. Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology 2002, 35:630-634.
43. Triantos C.K., Nikolopoulou V., Burroughs A.K. Review article: the therapeutic and prognostic benefit of portal pressure reduction in cirrhosis. Aliment Pharmacol Ther 2008, 28:943-952.
44. Yagi S., Iida T., Taniguchi K., Hori T., Hamada T., Fujii K., et al. Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation. Liver Transpl 2005, 11:68-75.